Cesca Therapeutics (KOOL) Falls on Q2 Loss

Cesca Therapeutics Inc (NASDAQ: KOOL) faded 4.9% to $3.03. Cesca Therapeutics reported a Q2 loss of $0.34 per share on revenue of $4.005 million. Share volume was 44,000, compared to an all-day average of 184,000